{
    "root": "5a66c5f5-1410-4643-a24a-dfccb5b49bdd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metoprolol Succinate",
    "value": "20250227",
    "ingredients": [
        {
            "name": "METOPROLOL SUCCINATE",
            "code": "TH25PD4CCB"
        },
        {
            "name": "ACETYLTRIBUTYL CITRATE",
            "code": "0ZBX0N59RZ"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "ETHYLCELLULOSE (10 MPA.S)",
            "code": "3DYK7UYZ62"
        },
        {
            "name": "HYDROGENATED COTTONSEED OIL",
            "code": "Z82Y2C65EA"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "METHYLENE CHLORIDE",
            "code": "588X2YUY0A"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "metoprolol succinate extended-release tablets beta-adrenergic blocker indicated treatment : \u2022 hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) \u2022 angina pectoris ( 1.2 ) \u2022 heart failure , reduce risk cardiovascular mortality heart failure hospitalizations patients heart failure . ( 1.3 )",
    "contraindications": "\u2022 administer daily . titrate weekly longer intervals needed tolerated . ( 2 ) \u2022 hypertension : starting dose 25 100 mg. ( 2.1 ) \u2022 angina pectoris : starting dose 100 mg. ( 2.2 ) \u2022 heart failure : starting dose 12.5 mg 25 mg. ( 2.3 ) \u2022 switching immediate release metoprolol metoprolol succinate extended-release tablets : total daily dose metoprolol succinate extended-release tablets . ( 2 )",
    "warningsAndPrecautions": "metoprolol succinate extended-release tablets usp , 25 mg white off-white , oval shaped , film-coated tablets , debossed \u201c \u201d \u201c 1 \u201d separated breakline one side breakline side . supplied : overbagged 10 extended-release tablets per bag , ndc 55154-4698-0 store 20\u00b0-25\u00b0c ( 68\u00b0-77\u00b0f ) ; [ usp controlled room temperature . ] protection : blister torn broken .",
    "adverseReactions": "metoprolol succinate extended-release tablets contraindicated severe bradycardia , second third degree heart block , cardiogenic shock , decompensated heart failure , sick sinus syndrome ( unless permanent pacemaker place ) , patients hypersensitive component product .",
    "indications_original": "Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: \u2022 Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) \u2022 Angina Pectoris (1.2) \u2022 Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure. (1.3)",
    "contraindications_original": "\u2022 Administer once daily. Titrate at weekly or longer intervals as needed and tolerated. (2) \u2022 Hypertension: Starting dose is 25 to 100 mg. (2.1) \u2022 Angina Pectoris: Starting dose is 100 mg. (2.2) \u2022 Heart Failure: Starting dose is 12.5 mg or 25 mg. (2.3) \u2022 Switching from immediate release metoprolol to metoprolol succinate extended-release tablets: use the same total daily dose of metoprolol succinate extended-release tablets. (2)",
    "warningsAndPrecautions_original": "Metoprolol succinate extended-release tablets USP, 25 mg are white to off-white, oval shaped, film-coated tablets, debossed with \u201cM\u201d and \u201c1\u201d separated by breakline on one side and breakline on other side. They are supplied:   \n                  Overbagged with 10 extended-release tablets per bag, NDC 55154-4698-0\n                  Store at 20\u00b0-25\u00b0C (68\u00b0-77\u00b0F); [See USP Controlled Room Temperature.]\n                  \n                     FOR YOUR PROTECTION: Do not use if blister is torn or broken.",
    "adverseReactions_original": "Metoprolol succinate extended-release tablets are contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated heart failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product."
}